RXRX
RECURSION PHARMACEUTICALS-A
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-22.27%
Annual Growth
4 years average annual growth
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.
📈 Performance
Price History*
-79.17%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$6.40
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RXRX
7
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
16 weeks
💵 Average investment amount
$640
⏰ Last time a customer invested in RXRX
13 days
RXRX investor breakdown
💵 Income of investors
More than 200k
150k - 200k
25%
100k - 150k
50k - 100k
25%
Less than 50k
50%
👶 Age of investors
18 - 25
14%
26 - 34
14%
35 - 90
71%
🙋 Legal gender of investors
Female
43%
Male
57%
Pearlers who invest in RXRX also invest in...
🙌 Performance (5Yr p.a)
494.41%
📊 Share price
$135.40 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
43.30%
📊 Share price
$84.77 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
17.40%
📊 Share price
$294.73 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
38.26%
📊 Share price
$567.16 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
